Protein family
The protein has not catalytic activity
Protein sequence
Protein function
Catalytic activity
PDB | Resolution (Å) | PDB name |
---|---|---|
1AXC | 2.6 | HUMAN PCNA |
2ZVV | 2.0 | Crystal structure of Proliferating cellular nuclear antigen 1 and Short peptide from human P21 |
2ZVW | 2.5 | Crystal structure of Proliferating cell nuclear antigen 2 and Short peptide from human P21 |
4RJF | 2.0072 | Crystal structure of the human sliding clamp at 2.0 angstrom resolution |
5E0U | 1.93 | Human PCNA variant (S228I) complexed with p21 at 1.9 Angstroms |
6CBI | 2.75 | PCNA in complex with inhibitor |
6CEJ | Solution structure of a 14mer fragment of the p21 protein | |
6CIV | Lactam cyclised mimetic of a fragment of p21 | |
6CIX | Lactam cyclised mimetic of a fragment of p21 | |
6P8H | 3.19 | Crystal structure of CDK4 in complex with CyclinD1 and P21 |
7KQ0 | 2.4 | PCNA bound to peptide mimetic |
7KQ1 | 3.3 | PCNA bound to truncated peptide mimetic |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0006974 | DNA damage response |
Biological Process | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
Biological Process | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
Biological Process | GO:0000082 | G1/S transition of mitotic cell cycle |
Biological Process | GO:0007265 | Ras protein signal transduction |
Biological Process | GO:0071493 | cellular response to UV-B |
Biological Process | GO:0034198 | cellular response to amino acid starvation |
Biological Process | GO:0031668 | cellular response to extracellular stimulus |
Biological Process | GO:0071480 | cellular response to gamma radiation |
Biological Process | GO:0071479 | cellular response to ionizing radiation |
Biological Process | GO:0090398 | cellular senescence |
Biological Process | GO:0007507 | heart development |
Biological Process | GO:0097193 | intrinsic apoptotic signaling pathway |
Biological Process | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
Biological Process | GO:0030216 | keratinocyte differentiation |
Biological Process | GO:0043616 | keratinocyte proliferation |
Biological Process | GO:0007095 | mitotic G2 DNA damage checkpoint signaling |
Biological Process | GO:2000279 | negative regulation of DNA biosynthetic process |
Biological Process | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle |
Biological Process | GO:1905179 | negative regulation of cardiac muscle tissue regeneration |
Biological Process | GO:0030308 | negative regulation of cell growth |
Biological Process | GO:0008285 | negative regulation of cell population proliferation |
Biological Process | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity |
Biological Process | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
Biological Process | GO:0010629 | negative regulation of gene expression |
Biological Process | GO:0042326 | negative regulation of phosphorylation |
Biological Process | GO:0032091 | negative regulation of protein binding |
Biological Process | GO:0001933 | negative regulation of protein phosphorylation |
Biological Process | GO:1904706 | negative regulation of vascular associated smooth muscle cell proliferation |
Biological Process | GO:0090402 | oncogene-induced cell senescence |
Biological Process | GO:0030890 | positive regulation of B cell proliferation |
Biological Process | GO:0048146 | positive regulation of fibroblast proliferation |
Biological Process | GO:0043068 | positive regulation of programmed cell death |
Biological Process | GO:0045860 | positive regulation of protein kinase activity |
Biological Process | GO:0001934 | positive regulation of protein phosphorylation |
Biological Process | GO:2000379 | positive regulation of reactive oxygen species metabolic process |
Biological Process | GO:0006606 | protein import into nucleus |
Biological Process | GO:2000045 | regulation of G1/S transition of mitotic cell cycle |
Biological Process | GO:0010389 | regulation of G2/M transition of mitotic cell cycle |
Biological Process | GO:0051726 | regulation of cell cycle |
Biological Process | GO:1902806 | regulation of cell cycle G1/S phase transition |
Biological Process | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity |
Biological Process | GO:0090399 | replicative senescence |
Biological Process | GO:0090400 | stress-induced premature senescence |
Biological Process | GO:0042246 | tissue regeneration |
Biological Process | GO:0042060 | wound healing |
Molecular Function | GO:0030332 | cyclin binding |
Molecular Function | GO:0019912 | cyclin-dependent protein kinase activating kinase activity |
Molecular Function | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
Molecular Function | GO:0046872 | metal ion binding |
Molecular Function | GO:0140677 | molecular function activator activity |
Molecular Function | GO:0140678 | molecular function inhibitor activity |
Molecular Function | GO:0019901 | protein kinase binding |
Molecular Function | GO:0004860 | protein kinase inhibitor activity |
Molecular Function | GO:0140311 | protein sequestering activity |
Molecular Function | GO:0044877 | protein-containing complex binding |
Molecular Function | GO:0031625 | ubiquitin protein ligase binding |
Cellular Component | GO:0070557 | PCNA-p21 complex |
Cellular Component | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0016604 | nuclear body |
Cellular Component | GO:0005730 | nucleolus |
Cellular Component | GO:0005654 | nucleoplasm |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0032991 | protein-containing complex |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-198323 | AKT phosphorylates targets in the cytosol | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | Leaf | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | Leaf | R-HSA-1643685 | Disease |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | Leaf | R-HSA-168256 | Immune System |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-69202 | Cyclin E associated events during G1/S transition | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-69231 | Cyclin D associated events in G1 | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-69895 | Transcriptional activation of cell cycle inhibitor p21 | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-8866911 | TFAP2 (AP-2) family regulates transcription of cell cycle factors | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | Internal node | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8941855 | RUNX3 regulates CDKN1A transcription | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-8951664 | Neddylation | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | Leaf | R-HSA-1643685 | Disease |
R-HSA-9702518 | STAT5 activation downstream of FLT3 ITD mutants | Leaf | R-HSA-1643685 | Disease |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | Leaf | R-HSA-1643685 | Disease |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | Internal node | R-HSA-8953897 | Cellular responses to stimuli |
Location | ECO term | Pubmed |
---|---|---|
Cytoplasm | ECO:0000269 | PubMed:11463845 |
Nucleus | ECO:0000269 | PubMed:11463845 |
Nucleus | ECO:0000269 | PubMed:23213251 |
HPO ID | HPO name |
---|---|
HP:0000141 | Amenorrhea |
HP:0000169 | Gingival fibromatosis |
HP:0000716 | Depression |
HP:0000736 | Short attention span |
HP:0000787 | Nephrolithiasis |
HP:0000802 | Impotence |
HP:0000822 | Hypertension |
HP:0000845 | Elevated circulating growth hormone concentration |
HP:0000849 | Adrenocortical abnormality |
HP:0000853 | Goiter |
HP:0001012 | Multiple lipomas |
HP:0001254 | Lethargy |
HP:0001259 | Coma |
HP:0001289 | Confusion |
HP:0001293 | Cranial nerve compression |
HP:0001579 | Primary hypercortisolism |
HP:0001824 | Weight loss |
HP:0001944 | Dehydration |
HP:0002013 | Vomiting |
HP:0002014 | Diarrhea |
HP:0002018 | Nausea |
HP:0002019 | Constipation |
HP:0002020 | Gastroesophageal reflux |
HP:0002027 | Abdominal pain |
HP:0002039 | Anorexia |
HP:0002044 | Zollinger-Ellison syndrome |
HP:0002150 | Hypercalciuria |
HP:0002248 | Hematemesis |
HP:0002249 | Melena |
HP:0002315 | Headache |
HP:0002588 | Duodenal ulcer |
HP:0002659 | Increased susceptibility to fractures |
HP:0002666 | Pheochromocytoma |
HP:0002797 | Osteolysis |
HP:0002858 | Meningioma |
HP:0002888 | Ependymoma |
HP:0002890 | Thyroid carcinoma |
HP:0002893 | Pituitary adenoma |
HP:0002894 | Neoplasm of the pancreas |
HP:0003072 | Hypercalcemia |
HP:0003118 | Increased circulating cortisol level |
HP:0003144 | Increased serum serotonin |
HP:0003528 | Elevated calcitonin |
HP:0004349 | Reduced bone mineral density |
HP:0004398 | Peptic ulcer |
HP:0005605 | Large cafe-au-lait macules with irregular margins |
HP:0006723 | Intestinal carcinoid |
HP:0006744 | Adrenocortical carcinoma |
HP:0006767 | Pituitary prolactin cell adenoma |
HP:0006780 | Parathyroid carcinoma |
HP:0007449 | Confetti-like hypopigmented macules |
HP:0008200 | Primary hyperparathyroidism |
HP:0008208 | Parathyroid hyperplasia |
HP:0008291 | Pituitary corticotropic cell adenoma |
HP:0010615 | Angiofibromas |
HP:0011151 | Atypical absence status epilepticus |
HP:0011407 | Proportionate tall stature |
HP:0011759 | Pituitary gonadotropic cell adenoma |
HP:0011760 | Pituitary growth hormone cell adenoma |
HP:0011761 | Pituitary null cell adenoma |
HP:0011762 | Pituitary thyrotropic cell adenoma |
HP:0012197 | Insulinoma |
HP:0012232 | Shortened QT interval |
HP:0030404 | Glucagonoma |
HP:0030405 | Pancreatic endocrine tumor |
HP:0030445 | Pulmonary carcinoid tumor |
HP:0031058 | Impairment of activities of daily living |
HP:0032044 | Decreased vigilance |
HP:0040085 | Abnormal circulating aldosterone |
HP:0040306 | Decreased male libido |
HP:0100522 | Thymoma |
HP:0100570 | Carcinoid tumor |
HP:0100829 | Galactorrhea |
HP:0500167 | Hypergastrinemia |